Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy
Stopped IRB Study Closure
Conditions
- Kidney Cancer
- Leukemia
- Lymphoma
- Multiple Myeloma
- Plasma Cell Neoplasm
- Myelodysplastic Syndromes
Interventions
- BIOLOGICAL: anti-thymocyte globulin
- DRUG: cyclophosphamide
- DRUG: cyclosporine
- DRUG: fludarabine
- DRUG: mycophenolate mofetil
- PROCEDURE: stem cell transplantation
- RADIATION: total body irradiation
- DRUG: filgrastim
Sponsor
Masonic Cancer Center, University of Minnesota